Spectranetics Announces Partnership to Distribute the TAPAS Catheter

Spectranetics Corporation (Nasdaq: SPNC) today announced an agreement with ThermopeutiX, Inc. to commercialize the TAPAS catheter, a therapeutic infusion system. The product has recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and is awaiting the issuance of a CE certificate. It will be launched in a limited number of US and European hospitals in the first quarter of 2012. The TAPAS catheter is intended for targeted infusion of therapeutic and diagnostic agents in the peripheral vasculature.